Zacks Investment Research
07 Jan 2026, 17:41 UTC · 45w ago
HOLX or SONVY: Which Is the Better Value Stock Right Now?
Impact · against what's priced in
Hologic appears to be a more attractive value play based on its current Zacks Rank and valuation metrics, while Sonova faces significant headwinds. The data suggests a divergence in earnings outlooks and value profiles between the two medical instrument providers.
- HOLX+0.40
No priced-in read yet
- In context
Hologic is currently rated as a Zacks Rank #2 (Buy) with a 'B' value grade and a forward P/E of 16.63, indicating a favorable earnings outlook and valuation.
Read from the article alone

Search tags




